Kiesel, Lisa Marie http://orcid.org/0000-0002-0848-5490
Bertsche, Astrid http://orcid.org/0000-0003-2832-0156
Kiess, Wieland http://orcid.org/0000-0003-4118-9455
Siekmeyer, Manuela
Bertsche, Thilo http://orcid.org/0000-0002-4930-6655
Neininger, Martina Patrizia http://orcid.org/0000-0002-5208-0888
Funding for this research was provided by:
Universität Leipzig
Article History
Received: 1 September 2022
Accepted: 2 January 2023
First Online: 28 February 2023
Declarations
:
: A Bertsche reports grants from UCB Pharma GmbH and honoraria for speaking engagements from Biogen GmbH, Desitin Arzneimittel GmbH, Eisai GmbH, GW Pharma GmbH, Neuraxpharm GmbH, Shire/Takeda GmbH, UCB Pharma GmbH, and ViroPharma GmbH. The other authors declare they have no financial or non-financial benefits received or will receive from any party related directly or indirectly to the subject of this article.
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of the Medical Faculty, Leipzig University, Germany (127/19-ek). As this was a retrospective study and data were collected from patient records without any influence on patients’ treatment, the ethics committee waived informed consent.